Login / Signup

Equitable Access to Research Benefits: Considerations for COVID-19 Vaccine Development and Clinical Trial Crossover.

Danish ZaidiJennifer MillerTanvee VarmaDowin BoatrightPhoebe Friesen
Published in: The American journal of bioethics : AJOB (2021)
Keyphrases
  • clinical trial
  • coronavirus disease
  • open label
  • double blind
  • sars cov
  • phase ii
  • placebo controlled
  • study protocol
  • phase iii